Rosine Guimbaud
9PUBLICATIONS
97CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade
|Jun 21, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study.Jean-Frédéric Blanc, Mohamed Bouattour, Ludovic Gauthier
|May 16, 2025
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma.Michel Ducreux, Romain Desgrippes, Yves Rinaldi
|Nov 25, 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).Thomas Walter, Thierry Lecomte, Julien Hadoux
|Oct 27, 2023
Exploring the basis of heterogeneity of cancer aggressiveness among the mutated POLE variants.Janick Selves, Helena de Castro E Gloria, Anne-Cécile Brunac
|Apr 24, 2022
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.Sahir Javed, Stéphane Benoist, Patrick Devos
Pageof 2
Frequent Collaborators
3 joint publications
Jean-Baptiste Bachet
3 joint publications
Olivier Bouche
3 joint publications
Thierry Lecomte
2 joint publications
Jean-Philippe Metges
2 joint publications
David Tougeron
2 joint publications
Michel Ducreux
2 joint publications
Christelle de la Fouchardiere
2 joint publications
Romain Cohen
1 joint publications
Christophe Borg
1 joint publications
Jean-Marc Phelip
